+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rivastigmine"

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • December 2024
  • 125 Pages
  • Global
From
From
From
From
Alzheimer's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Alzheimer's Disease Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Lewy Body Dementia Treatment Market Report 2025 - Product Thumbnail Image

Lewy Body Dementia Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Alzheimer's Drugs Market Report 2025 - Product Thumbnail Image

Alzheimer's Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 240 Pages
  • Global
From
From
From
Alzheimer's Disease - Pipeline Insights, 2024 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Insights, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
From
Alzheimer's Therapeutics Market Report 2022-2032 - Product Thumbnail Image

Alzheimer's Therapeutics Market Report 2022-2032

  • Report
  • December 2022
  • 196 Pages
  • Global
From
Loading Indicator

Rivastigmine is a drug used to treat symptoms of Alzheimer's disease and other forms of dementia. It is a cholinesterase inhibitor, meaning it works by increasing the amount of a chemical messenger in the brain that helps nerve cells communicate with each other. It is used to treat mild to moderate dementia caused by Alzheimer's disease or Parkinson's disease. It is also used to treat mild to moderate dementia caused by Lewy body dementia. Rivastigmine is available in both capsule and patch form. Rivastigmine is part of the Central Nervous System (CNS) drugs market, which includes drugs used to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. CNS drugs are used to treat a wide range of conditions, from mild to severe. The CNS drugs market is highly competitive, with many companies offering similar products. Some companies in the Rivastigmine market include Novartis, Pfizer, Mylan, and Teva Pharmaceuticals. Show Less Read more